Doug Brown, Senior Vice President of Value & Access, COEUS, Appointed by the Government Accountability Office to the Medicaid and CHIP Payment and Access Commission (MACPAC)
2024年5月8日 - 11:07PM
ビジネスワイヤ(英語)
Brown Is One of Two New Appointees Who Will
Serve Through 2027
COEUS is pleased to announce that Doug Brown, the company’s
Senior Vice President of Value and Access, has been appointed to
the Medicaid and CHIP Payment and Access Commission (MACPAC). Brown
is one of two new appointees, four reappointments, and one Vice
Chairman named today by Gene L. Dodaro, Comptroller General of the
United States and head of the U.S. Government Accountability Office
(GAO).
“The men and women who serve on this commission bring an
impressive level of knowledge and experience to advise Congress on
Medicaid and the Children’s Health Insurance Program,” Dodaro said.
“I am very pleased to announce today’s two new appointments, four
reappointments, as well as the naming of the new Chair.”
Brown and his newly appointed co-member, Michael Nardone, will
serve until their current term expires in April 2027. Current
members Heidi Allen, Robert Duncan, Verlon Johnson, and John
McCarthy were reappointed to new terms, which will also expire in
April 2027. Verlon Johnson has also been named the Commission’s
Chair, and Robert Duncan will continue as the Vice Chair.
“I’m honored to be appointed by GAO to serve as a MACPAC
Commissioner,” stated Brown. “It’s a privilege to serve the
non-partisan legislative branch agency that provides policy and
data analysis and makes recommendations to Congress, the Secretary
of the U.S. Department of Health and Human Services, and the states
on a wide array of issues affecting Medicaid and the State
Children’s Health Insurance Program (CHIP). I look forward to
working closely with the MACPAC staff and my fellow Commissioners
to ensure that Medicaid and CHIP policy evolves to meet the current
and future needs of each program and the millions of people they
serve.”
The Children’s Health Insurance Program (CHIP) Reauthorization
Act of 2009 established MACPAC to review Medicaid and CHIP access
and payment policies and to advise Congress on issues affecting
Medicaid and CHIP. The Act directs the Comptroller General to
appoint MACPAC’s members.
Doug Brown, RPh, MBA, is Senior Vice President of Value and
Access at COEUS, with over 30 years of pharmacy management
experience. Mr. Brown provides executive level healthcare
consulting and market access support services to life science
companies and healthcare organizations, including the development
of value- and outcomes-based contracting strategies with state
Medicaid programs, pharmacy benefit administrators, manufacturers,
and the Centers for Medicare & Medicaid Services. Prior to
joining COEUS in 2020, he served in several roles for Magellan Rx
Government, including as the Chief Strategy Officer. While at
Magellan, he led preferred drug list management for more than half
the state Medicaid programs in the country, provided subject matter
expertise on federal and state government legislation that impacted
state Medicaid programs, and offered policymakers a national view
of evolving events in Medicaid. Mr. Brown is a registered
pharmacist and holds a Bachelor of Science in pharmacy from the
University of Rhode Island and a Master of Business Administration
from Virginia Commonwealth University.
About COEUS
Established in 2009, COEUS is a leading healthcare consulting,
communications, technology, and talent firm. The company offers
clients a variety of services, as well as SaaS technology
platforms, for various stakeholders throughout the healthcare
ecosystem including all payers and emerging or more established
drug manufacturers. Leveraging the deep knowledge and experience of
the company’s many subject matter experts, COEUS works on all drug
types with a particular focus on cell and gene therapies, rare
diseases, and oncology. The company also has unique expertise in
the creation and management of value-based agreements by leveraging
COEBRA™, the company’s evidence and outcomes adjudication platform.
In its 15-year history, the company has supported the launch of
more than 130 pharmaceutical brands and has worked with more than
300 pharma clients including many top global pharmaceutical
manufacturers. To learn more about COEUS and the company’s
offerings, visit 1COEUS.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240507116587/en/
Owen Murphy e: omurphy@1coeus.com Ph: 215.680.0155